Sfoglia per AUTORE
NOWAKOWSKI G
Collezione ASL Biella

  

Items : 5

Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature in Blood Advances

2024
ASL Biella

Bommier C; Link BK; Gysbers BJ; Maurer MJ; Larson MC; Khurana A; Wang Y; Thompson CA; Chihara D; Alderuccio JP; Koff JL; Epperla N; Conconi A; Lossos IS; Nowakowski GS; Feldman AL; Habermann TM; King RL; Cerhan JR;

Early complete response as a validated surrogate marker in extranodal marginal zone lymphoma systemic therapy in Blood

2024
ASL Biella

Bommier C; Zucca E; Chevret S; Conconi A; Nowakowski G; Maurer MJ; Cerhan JR; Thieblemont C; Lambert J;

Time to Complete Response within 24 Months As a Good Surrogate Marker of 8 Year-Progression Free Survival in Extranodal Marginal Zone Lymphoma in Blood

2022
ASL Biella

Bommier C; Conconi A; Zucca E; Nowakowski GS; Cerhan JR; Thieblemont C; Lambert J;

Primary extranodal follicular lymphoma in a large retrospective survey of the international extranodal lymphoma study group (IELSG31) in Hematological Oncology

2021
ASL Biella

Conconi A; Vannata B; Janikova A; Ramirez A; Lobetti Bodoni C; Nowakowski G; Mian M; Ferreri AJM; Ryan G; Pangalis GA; Cabrera ME; Luminari S; Montoto S; Tsang R; Aurer I; Visco C; Mazzucchelli L; Trneny M; Gaidano G; Federico M; Lopez-Guillermo A; Pro B; Zucca E;

ABCL-135: RE-MIND: A Comparison of Tafasitamab (MOR208) + Lenalidomide (L-MIND) Versus Lenalidomide Monotherapy (Real-World Data) in Transplant-Ineligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Clinical Lymphoma, Myeloma and Leukemia

2020
ASL Biella

Rodgers T; Luigi Zinzani P; Marino D; Frezzato M; Maria Barbui A; Castellino C; Meli E; Conconi A; Cascavilla N; Cavallo F; H Fowler N; Feinberg B; Tillmanns S; Parche S; Fingerle-Rowson G; Winderlich M; Ambarkhane S; Salles G; Nowakowski G;